ICD-10 Coding for Myopathy(G71.2, G72.0)
Complete ICD-10-CM coding and documentation guide for Myopathy. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Myopathy
Code Comparison: When to Use Each Code
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| G71.2 | Congenital myopathy | Use when genetic or biopsy evidence confirms a congenital myopathy. |
|
| G72.0 | Drug-induced myopathy | Use when myopathy is directly linked to drug exposure, such as statins. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information: ICD-10 code for drug-induced myopathy
Essential facts and insights about Myopathy
Primary ICD-10-CM Codes for myopathy
Decision Criteria
clinical Criteria
- Confirmed genetic mutation associated with congenital myopathy
Applicable To
- Central core disease
- Nemaline myopathy
Excludes
- Metabolic myopathies (E74.0-)
Clinical Validation Requirements
- Genetic testing confirming mutation
- Muscle biopsy showing characteristic features
Code-Specific Risks
- Misclassification if genetic testing is not performed
Coding Notes
- Ensure genetic confirmation for accurate classification.
G72.0 - Drug-induced myopathy
Use when myopathy is directly linked to drug exposure, such as statins.
Applicable To
- Statin-induced myopathy
Excludes
- Myopathy due to other specified causes (G72.8)
Clinical Validation Requirements
- History of drug exposure
- Elevated CK levels
- EMG showing myopathic changes
Coding Notes
Document the specific drug and its relationship to the myopathy.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Myopathy to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code G71.2.
Impact
Clinical: May lead to inappropriate treatment decisions., Regulatory: Non-compliance with documentation standards., Financial: Potential for claim denials.
Mitigation Strategy
Always document the specific drug and its temporal relationship to symptoms.
Impact
Reimbursement: May lead to claim denials or reduced reimbursement., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases the accuracy of health data.
Mitigation Strategy
Always document and code the specific type of myopathy when possible.
Impact
High risk of audit if unspecified codes are used without supporting documentation.
Mitigation Strategy
Use specific codes with detailed clinical documentation.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Myopathy, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Myopathy
Use these documentation templates to ensure complete and accurate documentation for Myopathy. These templates include all required elements for proper coding and billing.
Patient with drug-induced myopathy
Specialty: NeurologyRequired Elements
- Patient history of drug exposure
- CK levels
- EMG findings
- Muscle biopsy results
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Myopathy? Ask your questions below.